Literature DB >> 7850872

Ultrastructure of cultured human orbital fibroblasts.

R C Henrikson1, T J Smith.   

Abstract

The fine structure of cultured human orbital fibroblasts was investigated by transmission electron microscopy. One culture was derived from a patient with severe Graves' ophthalmopathy, the other from a donor without inflammatory orbital disease. Despite their known differences in metabolism, orbital fibroblasts from either source revealed no ultrastructural differences. The cells had extensive thin cytoplasmic processes. The perinuclear areas contained multiple assemblies of Golgi membranes, modest amounts of rough endoplasmic reticulum, intermediate filaments, and lysosome-like structures. Glycogen deposits were noted both in the perinuclear cytoplasm and in the thin processes. These ultrastructural features of orbital fibroblasts are the same as those of fibroblasts from other anatomic regions.

Entities:  

Mesh:

Year:  1994        PMID: 7850872     DOI: 10.1007/bf00331384

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  14 in total

1.  The Pathologic Changes in the Orbit in Progressive Exophthalmos, with Special Reference to Alterations in the Extra-Ocular Muscles and the Optic Discs.

Authors:  J L McCool; H C Naffziger
Journal:  Trans Am Ophthalmol Soc       Date:  1932

Review 2.  Connective tissue, glycosaminoglycans, and diseases of the thyroid.

Authors:  T J Smith; R S Bahn; C A Gorman
Journal:  Endocr Rev       Date:  1989-08       Impact factor: 19.871

3.  Pleotrophic action of interferon gamma in human orbital fibroblasts.

Authors:  P J Higgins; T J Smith
Journal:  Biochim Biophys Acta       Date:  1993-03-24

4.  Bidimensional gel electrophoretic analysis of protein synthesis and response to interferon-gamma in cultured human dermal fibroblasts.

Authors:  T J Smith; P J Higgins
Journal:  Biochim Biophys Acta       Date:  1993-06-19

5.  n-Butyrate inhibition of hyaluronate synthesis in cultured human fibroblasts.

Authors:  T J Smith
Journal:  J Clin Invest       Date:  1987-05       Impact factor: 14.808

6.  Stimulation of glycosaminoglycan accumulation by interferon gamma in cultured human retroocular fibroblasts.

Authors:  T J Smith; R S Bahn; C A Gorman; M Cheavens
Journal:  J Clin Endocrinol Metab       Date:  1991-05       Impact factor: 5.958

7.  Interferon gamma regulation of de novo protein synthesis in human dermal fibroblasts in culture is anatomic site dependent.

Authors:  T J Smith; P J Higgins
Journal:  J Invest Dermatol       Date:  1993-03       Impact factor: 8.551

8.  Regulation of glycosaminoglycan synthesis by thyroid hormone in vitro.

Authors:  T J Smith; Y Murata; A L Horwitz; L Philipson; S Refetoff
Journal:  J Clin Invest       Date:  1982-11       Impact factor: 14.808

9.  Dexamethasone regulation of glycosaminoglycan synthesis in cultured human skin fibroblasts. Similar effects of glucocorticoid and thyroid hormones.

Authors:  T J Smith
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

10.  Hormonal regulation of hyaluronate synthesis in cultured human fibroblasts: evidence for differences between retroocular and dermal fibroblasts.

Authors:  T J Smith; R S Bahn; C A Gorman
Journal:  J Clin Endocrinol Metab       Date:  1989-11       Impact factor: 5.958

View more
  4 in total

Review 1.  Novel aspects of orbital fibroblast pathology.

Authors:  T J Smith
Journal:  J Endocrinol Invest       Date:  2004-03       Impact factor: 4.256

Review 2.  TSH-receptor-expressing fibrocytes and thyroid-associated ophthalmopathy.

Authors:  Terry J Smith
Journal:  Nat Rev Endocrinol       Date:  2015-01-06       Impact factor: 43.330

Review 3.  Insights into the role of fibroblasts in human autoimmune diseases.

Authors:  T J Smith
Journal:  Clin Exp Immunol       Date:  2005-09       Impact factor: 4.330

Review 4.  Potential Roles of CD34+ Fibrocytes Masquerading as Orbital Fibroblasts in Thyroid-Associated Ophthalmopathy.

Authors:  Terry J Smith
Journal:  J Clin Endocrinol Metab       Date:  2019-02-01       Impact factor: 5.958

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.